
New hope of a cure for amyloidosis sufferers
In New Zealand, Professor Ed Gane is working with families affected by hereditary amyloidosis, as research into new treatment approaches brings new hope.
Newsroom


In New Zealand, Professor Ed Gane is working with families affected by hereditary amyloidosis, as research into new treatment approaches brings new hope.

Amyloidosis explained: how amyloid deposits affect the organs, the signs and symptoms to look out for, and the tests used to reach a diagnosis.

Diagnosis, treatment and research: how the care of cardiac amyloidosis has evolved over recent decades, based on a review of three parallel advances.

Amyloidosis can affect the heart, kidneys and nerves. Why regular physical activity adapted to each person can play a useful role alongside treatment.

Cardiac amyloidosis often goes unrecognised, even by doctors. What it is, a case seen in an emergency department, and why earlier diagnosis matters.
At a World Heart Federation forum in Geneva in May 2023, patient representatives, including for ATTR cardiomyopathy, spoke about rare heart diseases.
Plain language summaries of key ATTR amyloidosis clinical trial publications are now available in seven languages, to make results accessible to patients.

Early results for an antibody designed to clear transthyretin amyloid deposits were presented at a heart failure congress, pointing to a possible new approach.

ATTRv amyloidosis is the hereditary form of ATTR. Its symptoms, its impact on daily life, how it is diagnosed and the treatment options, explained simply.
Join our mailing list and follow the work of the Amyloidosis Alliance, a few emails a year.